217 related articles for article (PubMed ID: 7243136)
1. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
Roy S; Shaw ST
Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
[TBL] [Abstract][Full Text] [Related]
2. Treatment of IUD related menorrhagia by indomethacin.
Yarkoni S; Anteby SO
Clin Exp Obstet Gynecol; 1984; 11(4):120-2. PubMed ID: 6437699
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
4. IUD-induced uterine bleeding.
El-badrawi HH; Hafez ES
Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins and menorrhagia.
Nygren KG; Rybo G
Acta Obstet Gynecol Scand Suppl; 1983; 113():101-3. PubMed ID: 6344539
[TBL] [Abstract][Full Text] [Related]
6. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
7. Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding.
Di Lieto A; Catalano D; Miranda L; Paladini A
Clin Exp Obstet Gynecol; 1987; 14(1):41-4. PubMed ID: 3102127
[TBL] [Abstract][Full Text] [Related]
8. [Management of abnormal bleeding in an intrauterine device user].
Desmons F; Adam-steen C
Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
[TBL] [Abstract][Full Text] [Related]
9. [Anti-prostaglandins in therapy for side effects of intrauterine contraceptive devices].
Sahmay S; Ertungealp E; Arvas M; Atasu T
Cerrahpasa Tip Fak Derg; 1987; 18(1-2):75-83. PubMed ID: 12283406
[TBL] [Abstract][Full Text] [Related]
10. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
Pan J; Yu Y; Chen G
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
[TBL] [Abstract][Full Text] [Related]
11. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
Bengtsson LP; Weström L
Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
13. Management of uterine bleeding by PGs or their synthesis inhibitors.
Toppozada M; El-Attar A; El-Ayyat MA; Khamis Y
Adv Prostaglandin Thromboxane Res; 1980; 8():1459-63. PubMed ID: 6769315
[TBL] [Abstract][Full Text] [Related]
14. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid.
Chan WY; Dawood MY; Fuchs F
Am J Obstet Gynecol; 1979 Sep; 135(1):102-8. PubMed ID: 474640
[TBL] [Abstract][Full Text] [Related]
15. [Intrauterine device-induced menorrhagia and endometrial content of prostacyclins].
Zhang JY; Luo LL
Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):167-8, 190. PubMed ID: 1395902
[TBL] [Abstract][Full Text] [Related]
16. Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen.
Hubacher D; Reyes V; Lillo S; Pierre-Louis B; Zepeda A; Chen PL; Croxatto H
Hum Reprod; 2006 Jun; 21(6):1467-72. PubMed ID: 16484309
[TBL] [Abstract][Full Text] [Related]
17. The role of prostaglandins and allied substances in uterine haemostasis.
Hagenfeldt K
Contraception; 1987 Jul; 36(1):23-35. PubMed ID: 3311624
[TBL] [Abstract][Full Text] [Related]
18. [Quantification of menstrual bleeding in women using intrauterine devices (IUDs)].
Pedron Neueo N
Gac Med Mex; 1992; 128(5):597-604; discussion 604-5. PubMed ID: 1307733
[TBL] [Abstract][Full Text] [Related]
19. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion].
Jensen HH; Blaabjerg J; Lyndrup J
Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090
[TBL] [Abstract][Full Text] [Related]
20. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
Arowojolu AO; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
